Literature DB >> 17026463

Genetic susceptibility to rheumatic heart disease and streptococcal pharyngitis: association with HLA-DR alleles.

F E Haydardedeoğlu1, H Tutkak, K Köse, N Düzgün.   

Abstract

Acute rheumatic fever (ARF) is a systemic inflammatory disease that develops as a consequence of an exaggerated immune response to group A beta-haemolytic streptococci, which causes pharyngitis. Major manifestations of ARF include carditis, arthritis and chorea. Several investigators have attempted to establish a relation between ARF and human leucocyte antigens (HLA). Heterogeneity in various studies has been found, although associations with certain antigens were reported. The aim of this study was to analyse whether HLA-DR alleles play a role in the resistance or susceptibility to streptococci-related disorders including rheumatic heart disease (RHD) as a sequela of ARF and recurrent streptococcal pharyngitis in Turkish patients. The study included 102 patients with RHD, 71 persons with recurrent streptococcal pharyngitis and 130 healthy controls. HLA-DR alleles were typed by using polymerase chain reaction (PCR)-sequence-specific primers. Positive association with HLA-DRB1*07 allele was found for RHD when compared with healthy controls [29.4% vs 13.1%; P < 0.01, P-corrected: P < 0.01, odds ratio (OR) 2.78, 95% confidence interval (CI) 1.43-5.26] and also for recurrent streptococcal pharyngitis (26.8% vs 13.1%; P < 0.05, P-corrected: P < 0.05, OR 2.44, 95% CI 1.17-3.56). The frequency of HLA-DRB1*11 allele was decreased in patients with RHD (23.5% vs 42.3%; P < 0.01, P-corrected: P < 0.01, OR 0.42, 95% CI 0.24-0.75). Data suggest that HLA-DRB1*07 allele may be a genetic factor in increasing the susceptibility to develop RHD and recurrent streptococcal pharyngitis. HLA-DRB1*11 allele seems to be a protective factor against RHD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17026463     DOI: 10.1111/j.1399-0039.2006.00678.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  6 in total

1.  HLA class I and class II HLA DRB profiles in Egyptian children with rheumatic valvular disease.

Authors:  Nashwa El-Hagrassy; Farha El-Chennawi; Maysaa El-Sayed Zaki; Hossam Fawzy; Adel Zaki; Nabeil Joseph
Journal:  Pediatr Cardiol       Date:  2010-02-10       Impact factor: 1.655

2.  The lack of genetic association of the Toll-like receptor 2 (TLR2) Arg753Gln and Arg677Trp polymorphisms with rheumatic heart disease.

Authors:  Nurşen Düzgün; Türker Duman; Filiz Ekşi Haydardedeoğlu; Hüseyin Tutkak
Journal:  Clin Rheumatol       Date:  2006-11-10       Impact factor: 3.650

Review 3.  The Genetic Control of the Rheumatic Heart: Closing the Genotype-Phenotype Gap.

Authors:  Atiyeh M Abdallah; Marawan Abu-Madi
Journal:  Front Med (Lausanne)       Date:  2021-03-24

4.  Glomerulonephritis causing acute renal failure during the course of bacterial infections. Histological varieties, potential pathogenetic pathways and treatment.

Authors:  Jorge I Zeledon; Robin L McKelvey; Karen S Servilla; Diedre Hofinger; Konstantin N Konstantinov; Suzan Kellie; Yijuan Sun; Larry W Massie; Michael F Hartshorne; Antonios H Tzamaloukas
Journal:  Int Urol Nephrol       Date:  2008       Impact factor: 2.266

5.  HLA class II DR and DQ genotypes and haplotypes associated with rheumatic fever among a clinically homogeneous patient population of Latvian children.

Authors:  Valda Stanevicha; Jelena Eglite; Dace Zavadska; Arturs Sochnevs; Ruta Shantere; Dace Gardovska
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

6.  Rheumatic heart disease in Uganda: the association between MHC class II HLA DR alleles and disease: a case control study.

Authors:  Emmy Okello; Andrea Beaton; Charles K Mondo; Paul Kruszka; Noah Kiwanuka; Richard Odoi-Adome; Juergen Freers
Journal:  BMC Cardiovasc Disord       Date:  2014-02-28       Impact factor: 2.298

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.